- Home
- GPK vs ROIV Comparison
GPK vs ROIV Comparison
Compare GPK & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPK
- ROIV
- Stock Information
- Founded
- GPK 2007
- ROIV 2014
- Country
- GPK United States
- ROIV United Kingdom
- Employees
- GPK N/A
- ROIV N/A
- Industry
- GPK Containers/Packaging
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- GPK Consumer Discretionary
- ROIV Health Care
- Exchange
- GPK Nasdaq
- ROIV Nasdaq
- Market Cap
- GPK 8.7B
- ROIV 8.4B
- IPO Year
- GPK 1992
- ROIV N/A
- Fundamental
- Price
- GPK $29.58
- ROIV $12.12
- Analyst Decision
- GPK Buy
- ROIV Strong Buy
- Analyst Count
- GPK 8
- ROIV 10
- Target Price
- GPK $31.31
- ROIV $17.39
- AVG Volume (30 Days)
- GPK 1.7M
- ROIV 4.7M
- Earning Date
- GPK 10-29-2024
- ROIV 11-11-2024
- Dividend Yield
- GPK 1.37%
- ROIV N/A
- EPS Growth
- GPK 2.61
- ROIV N/A
- EPS
- GPK 2.34
- ROIV 5.65
- Revenue
- GPK $9,094,000,000.00
- ROIV $158,303,000.00
- Revenue This Year
- GPK N/A
- ROIV $45.51
- Revenue Next Year
- GPK $1.68
- ROIV $37.40
- P/E Ratio
- GPK $12.58
- ROIV $2.19
- Revenue Growth
- GPK N/A
- ROIV 101.44
- 52 Week Low
- GPK $20.07
- ROIV $8.25
- 52 Week High
- GPK $30.66
- ROIV $13.24
- Technical
- Relative Strength Index (RSI)
- GPK 58.48
- ROIV 57.21
- Support Level
- GPK $28.53
- ROIV $12.16
- Resistance Level
- GPK $29.48
- ROIV $13.06
- Average True Range (ATR)
- GPK 0.58
- ROIV 0.40
- MACD
- GPK -0.04
- ROIV 0.01
- Stochastic Oscillator
- GPK 66.67
- ROIV 39.87
About GPK Graphic Packaging Holding Company
Graphic Packaging Holding Co is a holding company that manufactures and sells a variety of paper-based consumer packaging products through its subsidiaries. The company's reportable segments are; Paperboard Manufacturing, Americas Paperboard Packaging, and Europe Paperboard Packaging. The majority of the revenue is generated from its Americas Paperboard Packaging segment which includes paperboard packaging sold predominantly to consumer packaged goods (CPG) companies and cups, lids and food containers sold to foodservice companies and quick-service restaurants (QSR) serving the food, beverage, and consumer product markets in the Americas. Geographically, the company generates revenue from the Americas, Europe and Asia Pacific regions.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.